Login / Signup

Comparative Analysis of Dimethyl Fumarate and Teriflunomide in Relapsing Remitting Multiple Sclerosis.

Jannis MüllerSabine SchädelinJohannes LorscheiderPascal BenkertPeter HänniJürg SchmidJens KuhleTobias DerfussCristina GranzieraÖzgür Yaldizli
Published in: European journal of neurology (2023)
Analysis of real-world data showed that dimethyl fumarate treatment was associated with more favorable outcomes than teriflunomide.
Keyphrases
  • multiple sclerosis
  • white matter
  • electronic health record
  • big data
  • type diabetes
  • adipose tissue
  • rheumatoid arthritis
  • machine learning
  • deep learning
  • skeletal muscle
  • data analysis
  • smoking cessation